About Athyrium Capital Management

Athyrium is a specialized asset management company formed in 2008 to focus on investment opportunities in the broader healthcare and life sciences sectors encompassing biotechnology, pharmaceuticals, healthcare services, healthcare technology and medical devices and products.

Our Focus

The Athyrium team has substantial investment experience in the healthcare sector across a wide range of asset classes, including public equity, private equity, fixed income, royalties and other structured securities.

Athyrium advises funds with over $4.6 billion of committed capital. We value our investors and are thankful for the trust they have placed in us.

Up to $200 million per investment with ability to flex up opportunistically

Public and private companies

Commercial-stage companies with compelling products and differentiated services

Industry-leading management teams

Multi-year commitments with opportunity to upsize over time

Global investment mandate

Our History

 

2008

Timeline Image

Athyrium is formed.

2009

Timeline Image

Athyrium partners with Neuberger Berman

2013

Timeline Image

Athyrium closes Athyrium Opportunities Fund at $507 million of committed capital

2015

Timeline Image

Athyrium closes Athyrium Opportunities Fund II with $1.2+ billion of committed capital

2017

Timeline Image

Athyrium closes Athyrium Opportunities Fund III with $2.0+ billion of committed capital

2022

Timeline Image

Athyrium closes Athyrium Opportunities Fund IV with $1.2+ billion of committed capital

Our Investors

Our investors consist of public and corporation pension funds, charitable endowments, insurance companies, funds-of-funds, family offices, university endowments, and sovereign wealth funds.